PMP22 and Charcot-Marie-Tooth disease type 1A: However, in vivo studies in a mouse model of CMT1A linked with PMP22 aggregation showed that although rapamycin promoted peripheral nerve myelination it did not improve the overall neuromuscular function in these animals (Nicks et al., 2014).